Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
5
×
national blog main
national
national top stories
raleigh-durham blog main
san francisco blog main
venture capital
biotech
boston top stories
detroit blog main
funding
life sciences
medical devices
new york blog main
raleigh-durham top stories
san diego blog main
san francisco top stories
seattle blog main
startups
texas blog main
texas top stories
wisconsin blog main
boulder/denver blog main
detroit top stories
indiana blog main
investment
new york top stories
non-hodgkin lymphoma
novartis
people
pfizer
san diego top stories
seattle top stories
vc
wisconsin top stories
2025
abbvie
actavalon
acute myeloid leukemia
ad-comm
What
investors
5
×
cancer
company
developing
ipo
new
allogene
approach
attributes
bags
bio
biotechs
blood
broader
business
capital
charm
comes
control
crispr
detect
diversity
effect
entrepreneur
execs
external
factors
fearlessness
files
firms
focus
founders
grail
hot
house
immigration
immunotherapy
innovation
inside
intended
Language
unset
Current search:
investors
×
" boston blog main "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More